Dear Ms or Mr,
Regarding to the guidelines,
I am looking market authorization advice for our new product Paxlovid.
This drug is in clinical trial phase 3,
Pfizer company would make Paxlovid on the market following the accelerated procedure.
Do you are able to confirm that issue?
We will be pleased to send you every documents you need if it's necessary,
Best Regards,
Mélanie BORDIER,
Regulatory Affairs Director at Pfizer Company